Stablecoin Development Corporation Stock Price, News & Analysis
Company Description
Stablecoin Development Corporation (NYSE: SDEV) is a publicly traded asset management company in the Pharmaceutical Preparations sector. The company has a market capitalization of $38.2M, ranking #5,904 among all listed U.S. companies by market cap.
SDEV stock has declined 30.3% over the past year. Shares last traded at $1.31.
On a trailing twelve-month basis, Stablecoin Development Corporation reported net income of -$22.1M.
This page provides a comprehensive overview of SDEV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Stablecoin Development Corporation (SDEV) stock last traded at $1.31, up 6.11% from the previous close. Over the past 12 months, the stock has lost 30.3%. At a market capitalization of $38.2M, SDEV is classified as a micro-cap stock with approximately 27.1M shares outstanding.
SDEV Rankings
Latest News
Stablecoin Development Corporation has 2 recent news articles, with the latest published 7 days ago. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include crypto, earnings. View all SDEV news →
SEC Filings
Stablecoin Development Corporation has filed 10 recent SEC filings, including 4 Form SCHEDULE 13D/A, 2 Form 4, 2 Form SCHEDULE 13G, 2 Form 8-K. The most recent filing was submitted on May 22, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SDEV SEC filings →
Financial Highlights
operating income reached -$8.4M, and net income was -$22.1M. The company generated -$8.4M in operating cash flow. With a current ratio of 7.60, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Days to Cover History
SDEV Company Profile & Sector Positioning
Stablecoin Development Corporation (SDEV) operates in the Asset Management industry within the broader Pharmaceutical Preparations sector and is listed on the NYSE.